• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2500026 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2025-02-08 Pfizer Europe Ma Eeig;Wyeth Farma SA view
JYSB1600273 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2017-01-03 Wyeth Farma SA;Wyeth Pharmaceuticals Inc Certificate Issued 2017-04-10 view
CYSB2400087 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) Supplementary Application 2024-04-09 Chengdu Rongsheng Pharmaceuticals Co Ltd view
JYSB1900085 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2019-04-24 Wyeth Farma SA;Pfizer Ltd Certificate Issued 2019-10-30 view
CYSB2200011 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2022-01-10 SinoCelltech Ltd view
JYSZ1600015 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2016-05-10 Baxter AG;Baxalta Manufacturing Sàrl Certificate Issued 2017-04-19 view
JYSZ1800031 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2018-07-20 Bayer Healthcare LLC Certificate Issued 2019-06-03 view
JYSB1700078 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2017-05-03 Bayer Healthcare LLC Certificate Issued 2018-06-15 view
JYSB2200143 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-08-08 Bayer Healthcare LLC view
JYSB2101028 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-05-12 Bayer Healthcare LLC view
JYSB1800189 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2018-09-10 Wyeth Farma SA;Pfizer Ltd Certificate Issued 2019-02-02 view
JYSB1800050 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2018-03-23 Bayer Healthcare LLC Certificate Issued 2018-07-27 view
JYSB1900275 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2019-09-28 Pfizer Europe Ma Eeig;Wyeth Farma SA Certificate Issued 2019-10-28 view
CYSB2200010 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2022-01-10 SinoCelltech Ltd view
JYSB1800221 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2018-10-25 拜耳医药保健有限公司 Bayer Healthcare Company Ltd;Bayer Healthcare LLC Certificate Issued 2018-12-17 view
JYSB2200065 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-04-08 Novo Nordisk A/S view
JYSB1800112 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2018-05-17 Baxter AG;Baxalta Manufacturing Sàrl Filed 2018-05-30 view
JYSZ1700006 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products License Renew 2017-03-06 惠氏制药有限公司 Wyeth Pharmaceutical Co Ltd;Wyeth Farma SA;Pfizer Ltd Certificate Issued 2018-07-18 view
JYSB1900286 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2019-11-22 Baxter AG;Baxalta Manufacturing Sàrl Certificate Issued 2020-01-03 view
JYSB2400156 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-07-16 Pfizer Europe Ma Eeig;Wyeth Farma SA view